Clear 618 Results Filter Filter Results Type: Press Release Abiomed Announces Preliminary Q3 FY 2017 Revenue of $1147 Million Up 34% Over Prior Year Type: Press Release Abiomed Third Quarter Fiscal 2017 Earnings and Conference Call Notification Type: Press Release Abiomed to Present at the 35th Annual JP Morgan Healthcare Conference Type: Press Release Abiomed Impella CP Receives Expanded FDA Approval for High-Risk Percutaneous Coronary Intervention (PCI) Procedures Type: Press Release Abiomed Launches Impella Quality (IQ) Assurance Program and Shares Insight From Largest Database of Real-World Evidence of High-Risk PCI and Cardiogenic Shock Patients Type: Press Release Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study Type: Press Release Abiomed Announces Q2 FY 2017 Revenue of $103 Million Up 35% Over Prior Year Type: Landing The Procedure Type: Product Impella RP® Type: Landing Patient Stories … 35 36 37 38 …
